Merck KGAA: Reinventing the Mid-Sized Public Company
Executive Summary
Merck's goal is to build a leading position in specialty OTCs as well as a worldwide generics business, both goals designed to offset the risks of its R&D program. Its new business allows it to use its size as an advantage against smaller, specialized players while avoiding direct competition with the larger multinationals.